Skip to main content
HQY logo

HQY

Healthequity, Inc.
$94.50 -1.16 (-1.21%) At close · Jul 14
Market Cap
$7.90B
Shares
83,602,157

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$1.31B +9.5%
FY2026 Revenue FY2013–FY2026
Net Income
$215.2M +122.5%
FY2026 Net Income FY2013–FY2026
Gross Margin
69.52% +4.7pp
FY2026 Gross Margin FY2013–FY2026
Operating Margin
24.55% +11pp
FY2026 Operating Margin FY2013–FY2026
Diluted EPS
$2.46 +125.7%
FY2026 Diluted EPS FY2013–FY2026
Operating Cash Flow
$457.09M +34.5%
FY2026 Operating Cash Flow FY2013–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013
$1.34B $1.31B $1.2B $999.59M $861.75M $756.56M $733.57M $531.99M $287.24M $229.53M $178.37M $126.79M $87.86M $62.02M $46.09M
$392.11M $400.31M $422.52M $376.95M $369.81M $331.79M $318.24M $206.08M $106.05M $94.61M $72.02M
$945.12M $913.12M $777.26M $622.64M $491.94M $424.77M $415.33M $325.91M $181.19M $134.92M $106.36M $72.6M $47.97M $32.8M $24.12M
69.52% 64.78% 62.29% 57.09% 56.14% 56.62% 61.26% 63.08% 58.78% 59.63% 57.26% 54.6% 52.89% 52.33%
$268.84M $262.51M $239.51M $218.81M $193.38M $157.36M $124.81M $77.58M $35.06M $27.39M $22.38M $16.83M $10.5M $7.14M $4.23M
$96.09M $95.24M $90.74M $79.27M $68.85M $58.61M $49.96M $43.95M $29.5M $23.14M $18.32M $13.3M $10.62M $8.6M $7.8M
$125.53M $119.93M $132.26M $103.66M $97.47M $85.44M $84.49M $60.56M $33.04M $25.11M $20.15M $14.11M $8.34M $3.9M $3.37M
$152.3M $152.7M $157.8M $144.3M $148.9M $122.5M $99.9M $46.5M $14.7M $13.2M $11.2M $7.1M $4.8M $3.5M $2.7M
$154.66M $162.45M $153.08M $161.2M $137.19M $115.9M $55.35M $18.19M $15.95M $13.19M $8.6M $5.89M $4.27M $3.37M
$602.79M $590.66M $614.93M $504.94M $482.88M $449M $381.32M $248.9M $103.52M $80.5M $65.14M $46.46M $31.1M $21.28M $17.03M
$342.33M $322.46M $162.33M $117.7M $9.06M -$24.24M $34.01M $77.01M $77.67M $54.42M $41.21M $26.14M $16.87M $11.52M $7.09M
24.55% 13.53% 11.77% 1.05% -3.2% 4.64% 14.48% 27.04% 23.71% 23.1% 20.62% 19.21% 18.58% 15.39%
$477.11M $324.79M $270.78M $170.26M $112.95M $149.92M $132.36M $95.86M $70.37M $54.4M $34.74M $22.76M $15.79M $10.46M
$54.86M $57.13M $60.63M $55.46M $48.42M $36.57M $34.88M $24.77M $270K $274K $0 $44K $326K
-$43.44M -$45.02M -$46.3M -$42.66M -$47.15M -$42.5M -$29.87M -$33.85M -$1.85M -$2.23M -$1.09M -$589K -$1.11M -$6.15M -$590K
$0 $0 -$24K $0 $0
$298.89M $277.43M $116.03M $75.04M -$38.1M -$66.74M $4.14M $43.16M $75.82M $52.19M $40.12M $25.55M $15.76M $5.37M $6.5M
$68.19M $62.23M $19.33M $19.33M -$11.95M -$22.45M -$4.69M $3.49M $1.92M $4.83M $13.74M $8.94M $5.6M $4.14M -$4.67M
$230.7M $215.2M $96.7M $55.71M -$26.14M -$44.29M $8.83M $39.66M $73.9M $47.36M $26.38M $16.61M $10.17M $1.23M $11.17M
16.38% 8.06% 5.57% -3.03% -5.85% 1.2% 7.46% 25.73% 20.63% 14.79% 13.1% 11.57% 1.99% 24.23%
$26.38M $16.61M $12.06M -$7.13M $3.99M
$198.95M $209.49M $96.7M $55.71M -$26.14M -$44.29M $8.83M $39.66M $73.9M $47.3M $26.31M $16.52M $10.17M $1.23M $11.17M
USD/shares $2.50 $1.11 $0.65 -$0.31 -$0.53 $0.12 $0.59 $1.20 $0.79 $0.45 $0.29 $0.39 -$1.26 $0.81
USD/shares $2.46 $1.09 $0.64 -$0.31 -$0.53 $0.12 $0.58 $1.17 $0.77 $0.44 $0.28 $0.21 -$1.26 $0.25
shares 86.13M 86.87M 85.56M 84.44M 83.13M 74.24M 67.03M 61.84M 60.3M 58.62M 56.72M 31.18M 5.65M 4.92M
shares 87.47M 88.83M 86.96M 84.44M 83.13M 75.68M 68.45M 63.37M 61.85M 59.89M 58.86M 51.86M 5.65M 37.51M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2013–FY2026: $420.75M in buybacks, $51.04M in dividends.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
6.41×
Health Information Services median 1.34×
EV/EBIT
25.06×
Health Information Services median 25.06×
P/E (TTM)
35.39×
Health Information Services median 33.12×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component 2026-01-31 2025-01-31 2024-01-31 2023-01-31 2022-01-31 2021-01-31 2020-01-31 2019-01-31
Financial Service Other $636,800,000 $545,414,000 $386,594,000 $261,282,000 $186,119,000 $190,933,000 $181,892,000 $126,178,000
Service $485,022,000 $478,317,000 $455,690,000 $452,026,000 $443,608,000 $430,966,000 $262,868,000 $100,564,000
Credit And Debit Card $191,607,000 $176,043,000 $157,303,000 $148,440,000 $126,829,000 $111,671,000 $87,233,000 $60,501,000
Key facts CIK 1428336 CUSIP 42226A107 13F (30d) 37 filings 36 filers Visit website Investor relations